Saccharomyces boulardii CNCM I-745 Modulates the Fecal Bile Acids Metabolism During Antimicrobial Therapy in Healthy Volunteers

Saccharomyces boulardii CNCM I-745 (SB) is a probiotic yeast used to lower the incidence of antibiotic-associated Clostridium difficile (C. difficile) infection, though its mechanism of action remains unclear. Cholic acid is a primary bile acid, which triggers the germination and promotes the growth...

詳細記述

保存先:
書誌詳細
主要な著者: Ciaran Patrick Kelly, Caroline Chong Nguyen, Lola Jade Palmieri, Kumar Pallav, Scot E. Dowd, Lydie Humbert, Philippe Seksik, Andre Bado, Benoit Coffin, Dominique Rainteau, Toufic Kabbani, Henri Duboc
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2019-03-01
シリーズ:Frontiers in Microbiology
主題:
bile acids
probiotics
Saccharomyces boulardii
antibiotics
dysbiosis
microbiota
オンライン･アクセス:https://www.frontiersin.org/article/10.3389/fmicb.2019.00336/full
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料